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Infrared spectroscopyInfrared (IR) spectroscopy has been shown to be very reliable for the characterization, identiﬁcation
and quantiﬁcation of structural data. Particularly, the Attenuated Total Reﬂectance (ATR) technique which became
one of the best choices to study the structure and organization of membrane proteins and membrane-bound pep-
tides in biologically relevantmembranes. An important advantage of IR spectroscopy is its ability to analyzematerial
under a very wide range of conditions including solids, liquids and gases. This method allows elucidation of compo-
nent secondary structure elements of a peptide or protein in a global manner, and by using site speciﬁc isotope la-
beling allows determination of speciﬁc regions. A few advantages in using ATR-FTIR spectroscopy include; a
relatively simple technique, allow the determination of peptide orientation in themembrane, allow the determina-
tion of secondary structures of very small peptides, and importantly, the method is sensitive to isotopic labeling on
the scale of single amino acids. Many studies were reported on the use of ATR-FTIR spectroscopy in order to study
the structure and orientation of membrane bound hydrophobic peptides and proteins. The list includes native and
de-novo designed peptides, as well as those derived from trans-membrane domains of various receptors (TMDs).
The present review will focus on several examples that demonstrate the potential and the simplicity in using the
ATR-FTIR approach to determine secondary structures of proteins and peptides when bound, inserted, and
oligomerized within membranes. The list includes (i) a channel forming protein/peptide: the Ca2+ channel
phospholamban, (ii) a cell penetrating peptide, (iii) changes in the structure of a transmembrane domain located
within ordered and non-ordered domains, and (iv) isotope edited FTIR to directly assign structure to themembrane
associated fusionpeptide in context of a Key gp41StructuralMotif. Importantly, a unique advantage of infrared spec-
troscopy is that it allows a simultaneous study of the structure of lipids and proteins in intact biological membranes
without an introduction of foreign perturbing probes. Because of the long IR wavelength, light scattering problems
are virtually non-existent. This allows the investigation of highly aggregated materials or large membrane frag-
ments. This article is part of a Special Issue entitled: FTIR in membrane proteins and peptide studies.
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Infrared (IR) spectroscopy is very reliable for the characterization,
identiﬁcation and also quantiﬁcation of the acquired data. The de-
tailed technique and the theory behind it have been well documented
and partially summarized in an accompanied article by Arkin and
coworkers, and therefore will not be discussed here. An important
advantage of IR spectroscopy is its ability to analyze material under
a very wide range of conditions including solids, liquids and gases.
The Attenuated Total Reﬂectance (ATR) technique became one of
the best choices to study the structure and organization of membrane
proteins as well as membrane bound peptides in biologically relevant
model membrane bilayers. The experimenter uses ATIR-FTIR, to mea-
sure changes that occur in a totally internally reﬂected infrared beam
when the beam comes into contact with a sample (see Fig. 1).
For conditions of total internal reﬂection, the refractive index
of the crystal must be signiﬁcantly greater than that of the sample
(usually between 2.38 and 4.01 at 2000 cm−1). The most common
crystals are Germanium and ZnSe. Polypeptides absorb IR radiation
at speciﬁc frequency ranges based on the type of chemical bond
(i.e. single vs double), quality of bond vibration (i.e. stretch vs bend),
and the mass of the involved nuclei. IR absorbance in the amide I re-
gion (1600–1700 cm−1) is based primarily (80%) on stretching vibra-
tions of the individual C;O bonds of the component amino acids of a
protein or peptide [1]. The H-bonding network (amide N•••H•••O;C
carbonyl) of different secondary structure elements varies in strength
due to H-bond length and angle. The strength of the H-bond affects
absorption frequency of the C;O vibration, producing regions of re-
solvable absorption in the Amide I, which correspond to distinct
secondary structure [2]. This method allows elucidation of component
secondary structure elements of a peptide or protein in a global
manner. Many peptides andmost proteins contain a range of secondary
structures interspersed through the primary sequence.
A few advantages in using ATR-FTIR spectroscopy include: (i) It
represents a relatively simple technique to determine conformation
of membrane bound peptides and proteins in both monolayers
and bilayers. In monolayers the lipid can be transferred by the
Langmuir-Blodgett (LB) method to a germanium or other plate,
whereas bilayers can be built up using various methods such as the
LB/vesicle method [3] or by simply drying solutions of lipids, with
or without dissolved polypeptide, in chloroform methanol solution
[4] (to be described later in detail). (ii) The inﬂuence of membrane
associated peptides on the lipid acyl chain order, as well as the orien-
tation of the peptide when bound to membranes can also be achieved
rapidly and quantitatively. (iii) The secondary structure of very small
peptides bound to membranes can be determined. (iv) The method
is sensitive to isotopic labeling on the scale of single amino acids




Sample in contact with
evanescent wave
Fig. 1. An infrared beam is directed onto an optically dense crystal with a high refrac-
tive index at a certain angle. This internal reﬂectance creates an evanescent wave
that extends beyond the surface of the crystal into the sample held in contact with
the crystal. The reﬂected wave protrudes only a few microns (0.5–5 μm) beyond the
crystal surface and into the sample, and therefore, there must be efﬁcient contact
between the sample and the crystal surface.1.1. Sample preparation and data collection for ATR-FTIR measurements
The following paragraph outlines a brief description for measuring
ATR-FTIR absorption of peptides within the membrane environment,
and such data can be analyzed for polypeptide secondary structure
based on absorption in the Amide I region, for example. Usually, for
each spectrum, 200 or 300 scans are collected, with resolution of
4 cm−1. During data acquisition, the spectrometer is continuously
purged with dry N2 to eliminate the spectral contribution of atmo-
spheric water. Samples are prepared as follows: a mixture of desired
phospholipid (~1 mg) alone or with peptide (~30 μg) is deposited
on a ZnSe or Germanium horizontal ATR prism (80×7 mm). The
aperture angle of 45° yielded 25 internal reﬂections. It is important
to note that polypeptide samples puriﬁed using conventional HPLC
techniques typically include residual triﬂuoroacetate (CF3COO−)
counterions which strongly associate to the peptide, and these should
be replaced with chloride ions through several steps of peptide disso-
lution in 0.1 M HCl, followed by lyophilization. This will eliminate
the strong C;O stretching absorption band near 1673 cm−1 from
contaminant CF3COO− [5]. Lipid-peptide mixtures are prepared by
dissolving them together in a 1:2 MeOH/CH2Cl2 mixture, dispersing
the solution on the top of the prism and drying the solution in even
layers under a stream of dry nitrogen by moving a teﬂon bar back
and forth along the prism. Polarized spectra are recorded, and the
respective pure phospholipids in each polarization are subtracted to
yield the difference spectra. The background for each spectrum is a
clean ZnSe or Germanium prism. Hydration of the sample is achieved
by introduction of excess deuterium oxide (D2O) into a chamber
placed on top the ZnSe prism in the ATR casting and incubation for
2 h prior to acquisition of spectra. H/D exchange is considered com-
plete due to the complete shift of the amide II band. Any contribution
of D2O vapor to the absorbance spectra near the amide I peak region
is eliminated by subtraction of the spectra of pure lipids equilibrated
with D2O under the same conditions. Note that complete hydrogen/
deuterium exchange can take place only when all the amide I and II
bonds are exposed to the heavy water. As will be discussed later on,
this method is also utilized to determine the depth of the insertion
and organization of a peptide when bound to membranes.
1.2. ATR-FTIR data analysis of secondary structures
Prior to curve ﬁtting, a straight baseline passing through the ordi-
nates at 1700 and 1600 cm−1 is subtracted. To resolve overlapping
bands, the spectra are processed using PEAKFIT (Jandel Scientiﬁc,
San Rafael, CA) software. Second-derivative spectra accompanied by
13-data-point Savitsky–Golay smoothing are calculated to identify the
positions of the components bands in the spectra. These wavenumbers
are used as initial parameters for curveﬁttingwithGaussian component
peaks. Position, bandwidths, and amplitudes of the peaks are varied
until the followings were achieved:(i) the resulting bands shift by no
more than 2 cm−1 from the initial parameters; (ii) all the peaks have
reasonable half-widths (b20–25 cm−1); (iii) good agreement between
the calculated sum of all components and the experimental spectra
are achieved (r2>0.99). The relative contents of different secondary
structure elements are estimated by dividing the areas of individual
peaks, assigned to particular secondary structure, by the whole area of
the resulting amide I band. The results of four independent experiments
are usually averaged.
1.3. Hydrogen/deuterium (H/D) exchange to differentiate between α-helix
and random coil structures, and the extent of peptide insertion into the
membrane
Analyzing the shape and position of bands in the Amide I region can
yield information that can be utilized to obtain structural information
of a peptide or a protein in solution and in membranes. The presence
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speciﬁc α-helical, antiparallel and parallel β-sheets, and random
coil secondary structure types [6,7]. When an α-helix is bound to
membranes, the band center appears in the range from 1656 to
1658 cm−1, whereas in solution the band center occurs at lower
wavenumbers, approximately 1650 to 1655 cm−1. For backbone deu-
terium exchanged helices, the Amide I band can shift to a frequency
as low as 1644 cm−1 [8]. These examples highlight the relevance of
molecular environment, both macroscopic (i.e. membrane vs solution
solvated) and microscopic (i.e. nuclear isotope), when correlating IR
absorption with polypeptide conformation. It is therefore very impor-
tant to remember that there are no simple infrared spectra-secondary
structure correlations. FTIR can be a powerful tool if it is used in combi-
nation with other techniques like Circular Dichroism (CD) [9,10]. How-
ever, unambiguous assignment of bands in the ~1660–1640 cm−1
region is difﬁcult because of signiﬁcant overlap of the α-helical and
random structure absorption proﬁles. A common method to overcome
this difﬁculty is to exchange the hydrogen from the peptide N-H with
deuterium. If the peptide contains a signiﬁcant percentage of random
structure, the hydrogen to deuterium exchange will result in a large
shift in the position of the random structure (up to about 1646 cm−1),
whereas the position of theα-helical part will have only aminor change
in the position of the helical band. Therefore, the IR spectra of the
peptides are usually examined after complete deuteration [11]. Under
these conditions β-sheet vibrations absorb at 1640–1620 cm−1. It
should be noted however that there is considerable disagreement on
assignments for parallel and antiparallel β-sheets. Another assignment
includes absorbance centered at 1670 cm−1 which have been assigned
to β-turns, or turns.
Rapid exchange can take place only if the bonds contributing to
amide I and II absorption bonds are accessible to water. When they
are not accessible, or only partially accessible to water, this procedure
can give a measure for polypeptide depth of the insertion into the
hydrophobic core of the membrane. This approach was used in many
studies to locate membrane inserted domains in various peptides and
proteins [12–15].
1.4. Orientation of the peptides in their membrane-bound state
A combination between conventional and polarized FTIR spectros-
copy can be used to obtain data on the orientation of membrane
bound peptides, although the calculation of molecular orientation of
large proteins under these conditions can be complicated. However,
infrared absorption of the appropriate Amide I bands can be used to
obtain information on how speciﬁc portions of the protein or mem-
brane active peptides are oriented with respect to the bilayer. If we
consider a protein that is 100% helical and oriented along the z axis,
then the angle made by the C;O vibration (Amide I band) of the
peptide in the amide linkages along the protein backbone would be
approximately 27° with the center line of the α-helix [16–18]. The in-
tensity of the Amide I band obtained with perpendicular polarized
light will be very small under these conditions because the compo-
nent of the dipole moment along the y direction will be a small frac-
tion of that along the z axis. If we now consider that the helix is
aligned along the y direction, then the amide I band with parallel
polarized light will be small because the dipole moment along the z
and x direction will be small. The ratio of absorbance obtained with
parallel polarized light and perpendicular polarized light, designated
the dichroic ratio, can be used to estimate the angle made by the
C;O dipole (hence the α-helix) with the z axis. These calculations
assume a uniaxial orientation for the adsorbed peptides. Equations for
calculating molecular orientation were published and some of the
basic equations are given below [19–21]. These calculations require
refractive indices for the peptide-membrane layer and the aqueous
medium the protein is in contact with. Assuming that the backbone
C;O dipoles are approximately perpendicular to the molecular axisfor polypeptides in β-sheet conformation, molecular orientation of
β-sheets can be calculated as well.
Practically, the ATR electric ﬁelds of incident light are calculated
[17,22], where θ is the angle of a light beam to the prism normal at
the point of reﬂection (45°), and n21 is the reﬂective index of the
germanium n1 (taken to be 4.03) divided by the reﬂective index of
the membrane, n2 (taken to be 1.5). Under these conditions, Ex, Ey,
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The electric ﬁeld components together with the dichroic ratio
(deﬁned as the ratio between absorption of parallel to a mem-
brane plane), Ap, and perpendicularly polarized incident light (As)
(RATR=Ap/As) are used to calculate the orientation order parameter,




















where α is the angle between the transition moment of the amide I
vibration of an α-helix and the helix axis. A value of 27° for α is
usually used as discussed above [17,22]. Lipid order parameters are
obtained from the symmetric (b 2853 cm±1) and asymmetric
(b2922 cm±1) lipid stretching mode using the same equations,
setting α=90°.
1.5. Utilizing ATR-FTIR to study biological systems
Many studies were reported on the use of ATR-FTIR spectroscopy
to study the structure and orientation of membrane bound hydro-
phobic peptides and proteins. The list includes native and de-novo
designed peptides, as well as those derived from trans-membrane
domains of various receptors (TMDs). Naturally the present review
cannot discuss all the important studies reported so far but rather
will focus on several examples that demonstrate the potential and
the simplicity in using the ATR-FTIR approach to determine secondary
structures of proteins and peptides when bound, inserted, and
oligomerized within membranes.
1.5.1. A Channel Forming Protein/peptide
The Ca2+ Channel Phospholamban — Arkin et al. [11,13]
constructed a model of phospholamban, a 52 amino acid residue
membrane protein involved with the regulation of calcium levels.
The protein is composed of N-terminal 30 amino acid residues
which are mostly hydrophilic. The C-terminal 22 amino acid residues
are largely hydrophobic, anchor the protein in the membrane and are
responsible for Ca2+ selective ion conductance. It has been shown
that the transmembrane domains stabilize the protein as a pentamer
via speciﬁc interactions between the monomers. Studies with
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ﬂection Fourier transform infrared (ATR-FTIR) spectra of both the
full-length protein and a 28 residue peptide that includes the transmem-
brane domain reconstituted into phospholipid membranes revealed
mainly an α-helical structure for both. Furthermore, polarized ATR-FTIR
measurements revealed that both the cytosolic and transmembrane heli-
ces are oriented perpendicular to the membrane plane with a tilt of 28
(±6) degrees with respect to the membrane normal. Importantly, this
angle is in agreementwith biological andmolecularmodeling studies. Ex-
tension of the study by utilizing site-directed 13C isotope labeling (the
method will be discussed in details in the case of HIV fusion peptide),
support a model of phospholamban that predict the existence of an
α-helical hydrophobic region spanning the membrane domain. Later
on, Torres et al. introduced a new label, 1-13C;18O, at residues 42 and
43 that together for ATR-FTIR measurements yielded a higher resolution
structure for phospholamban (this labeling procedure is discussed in
details in the accompanying review by Arkin and coworkers [23]). Utiliz-
ing the same 1-13C;18O labeling method for the Inﬂuenza M2 H+ chan-
nel, Manor et al. [24] introduced a new analysis method, the FTIR line
width analysis, to give a reliablemeasure of the local polarity of a protein,
even when inserted into the membrane.
1.5.2. A cell penetrating peptide
A cell penetrating peptide A cell penetrating peptide—Ding et al., [25]
used ATR-FTIR spectroscopy to determine the structure of a cell penetrat-
ing peptide (CPP), named Pep-1 when bound to two types of negatively-
charged membranes under hydrated and deuterated conditions. The
two lipids were 1,2-dipalmitoyl-sn-glycero-3-hosphoglycerol (DPPG
and dDPPG) which represents gel-phase, and 1-palmitoyl-2-oleoyl-
sn-glycero-3-phospho-(1'-rac-glycerol) (POPG) which represents ﬂuid-
phase. They found that the peptide adopted a β-sheet conformation
within DPPG lipid bilayers and a mix of α-helical and β-sheet within
ﬂuid-phase POPG lipid bilayers. They also found that the orientation dis-
tribution of the peptide chain in the ﬂuid-phase bilayers depended on
the peptide concentration. Hence with rather simple experiments the
authors could demonstrate lipid bilayer phase and peptide concentra-
tion affects on the conformation and orientation of a CPP, which can
be crucial to the translocation process of CPPs.
1.5.3. Changes in the structure of a transmembrane domain located with-
in ordered and non-ordered domains
The advantage of ATR-FTIR spectroscopy over the extensively used
circular dichroism (CD) can be demonstrated for example in the study
of Castro and coworkers on the location of the transmembrane domains
(TMDs) of a membrane protein when inserted into the membrane [26].
The authors synthesized a 21-mer peptide corresponding to the single
TMD of the Fas death receptor and reconstituted it into mammalian raft
model membranes composed of an unsaturated glycerophospholipid,
sphingomyelin, and cholesterol. They demonstrated that Fas TMD is
preferentially localized in liquid-disordered membrane regions and
undergoes a strong reorganization as the membrane composition is
changed toward the liquid-ordered phase, which suggest that the stabil-
ity of non-clustered Fas TMD in liquid-disordered domains has a protec-
tive function against non-ligand-induced Fas clustering in lipid rafts.
Whereas the FTIR spectroscopy can yield information solely on the pep-
tide without the interference of the lipids that are applied at different
composition, CD spectroscopy is highly affected by both the type of lipids
as well as the physical organization of the different mixtures.
1.5.4. The structure and organization of the HIV-1 fusion peptide alone
and in context of key regions in gp41
The Structure and Organization of the HIV-1 Fusion Peptide Alone
and in Context of Key Regions in gp41 — Stable infection by HIV is ac-
complished by successful fusion between viral and target cell mem-
branes. Membrane fusion is catalyzed by the viral encoded envelope
glycoprotein gp160, which is composed of gp120–gp41 subunits,and this protein complex is localized in the viral envelope. The
gp120 glycoprotein binds cell receptor (CD4) and a co-receptor
(CXCR4 or CCR5) [27,28]. Following the attachment of gp120, gp41
undergoes conformational changes that enable it to catalyze the fu-
sion between the viral and the cellular membranes, or between
infected and uninfected bystander target cells [29–31]. Gp41 is com-
posed of several functional domains including the fusion peptide
(FP), the N-terminal heptad repeat (NHR), the loop, the C-terminal
heptad repeat (CHR), and the transmembrane domain (TMD)
[32,33] (Fig. 2). A proposed role of the FP, which sits at the
N-terminus of gp41, is to reduce the energy barrier for the fusion by
binding and dehydrating the outer bilayer at a localized site [34].
The fusion itself starts with the insertion of the FP into the host cell
membrane [35–37] but the details of its action are unclear. Orienta-
tion of membrane insertion can provide clues to a molecular mecha-
nism. An oblique orientation for SIV or HIV fusion peptides [38] has
been shown by both computation [39,40] and by experimental stud-
ies using ATR-FTIR [41–43].
Gp41 organizes as a trimer stabilized by the NHR which folds into
a parallel trimeric coiled coil [44,45]. This trimeric organization of the
NHR is expected to oligomerize the adjacent FP region. Such an as-
sembly places three FPs as parallel N-terminal appendages, free to in-
teract with themselves and the target membrane. The hydrophobic FP
is highly conserved, and it is known that the region is essential to viral
fusion based on mutation analysis [46–48]. Competition experiments
with expressed wild type and mutant gp41 [49], and the inhibitory
activity of free FP peptides toward viral fusion [50,51] suggest that:
(i) the structure of isolated synthetic FPs mimic the structure of na-
tive FP within the context of intact gp41, and (ii) the oligomerization
of the FP region is critical for fusion.
Elucidation of the structure and function of the FPwas complicated
by an inability to characterize the FP in the context of gp41. Therefore,
biophysical analysis was limited to FP fragments feasible to chemical
synthesis. Nevertheless, as indicated above these peptides should pre-
serve at least part of their native structure because they can interfere
with the assembly of the parental protein and inhibit fusion. Indeed,
such studies have produced a wealth of biophysical data for 23 and
33 residue N-terminal FP fragments. These studies have shown that
FP aggregates in solution [50,52–55], and readily binds to and inserts
into membranes [50,52,54,56–61].
Overall, structural characterization of the discrete FP has revealed
seemingly paradoxical data; α-helix or β-structure [38,52,56–
58,60,62–67]. For example, Schmick and Weliky [68] combined min-
imal isotope labeling with solid state NMR analysis of the 23 amino
acid FP attached to WKKKKKKA in bilayers to quantify alignment
and registry of FP β-strands, and their scheme allowed unambiguous
assignment of primarily anti-parallel alignment with most strands
crossing in the middle of the apolar FP region. This apparent dichoto-
mymay be explained by the different procedures that have been used
to incorporate the FP into the membrane and/or structural plasticity
inherent in the FP based on its primary sequence shown in Fig. 2
(highly enriched in Gly and Ala). However, during the fusion event,
both structures may be relevant and serve speciﬁc purposes. Never-
theless, an important challenge was to determine the structure of
the FP when stabilized by the functional gp41 ectodomain, and verify
that such a structure is related to its function.
1.5.4.1. ATR-FTIR studies support a β-sheet structure for FP
Earlier studies demonstrated that oligomerization of the discrete FP
(23 residue fragment) either through high peptide loading in the mem-
brane [60,63,69] or by cross-linking [66], stabilizes β-conformation in
membranes. Assuming tertiary FP assembly into predominant trimeric
oligomer state due to the adjacent trimeric coiled coil NHR or six-
helix-bundle motifs, likely FP β-structure models include either parallel
intermolecular (between strands) due to stearic constraints imposed
by adjacent NHR, or mixed inter- and intra-molecular anti-parallel.
gp41
N70







Fig. 2. Subunit organization of HIV-gp160 (gp120/gp41) envelope protein.
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in a model of quaternary organization of minimally two gp41 trimers,
with opposing gp41 molecules assembled through the N-terminal in-
terdigitation of antiparallel FP β-strands. To test such models, reliable
structural information should be based on FP when it is connected to
a long region of the intact gp41. As indicated before, the N-terminal
half of the PHI is characterized by the FP stabilized by the adjacent
auto-oligomerization domain (NHR) [70–72]. Shai and co-workers
reproduced this organization by engineering a peptide construct
containing both FP and NHR (named N70, marked in Fig. 2) [73]. Na-
tive gel and Western analysis of N70 suggests that while the NHR re-
gion contributes to trimeric assembly, the FP region directs higher
order assembly of trimers, with both types of assembly likely based
primarily on hydrophobic interactions [74]. One role of the NHR re-
gion is to shift equilibrium of oligomerization of the highly hydropho-
bic FP region from large to smaller oligomers (i.e. trimer, hexamer).
When small oligomer FP assembly was stabilized (through the
NHR), a key observation was a dramatic boost in membrane fusion
function relative to the discrete FP, thus suggesting that the structure
of the FP in the 70-mer N70 construct is more biological relevant [73].
1.5.4.2. Use of mutations to map the structural landscape of N70
One of the advantages of FTIR is its ability to differentiate clearly be-
tween different structures, particularly α-helix and β-sheet. One ap-
proach to determine the secondary structure of a deﬁned region
within a protein is to mutate speciﬁc amino acids and check whether
the α-helix and the β-sheet components were affected. Sackett and
Shai [75] utilized this approach to identify the fusion active conforma-
tion of the FP in context of N70. The initial approach took advantage
of well characterized mutations in both the FP and NHR coiled coil. Se-
lected mutations were chosen in the FP, the NHR and the loop between
them. These mutations reduced signiﬁcantly the infectivity of the intact
virus [76,77]. Using FTIR spectroscopy for wild type and mutant N70
constructs, the secondary structure organization was mapped and the
data indicate that the FP adopts β-structure while the NHR is helical
for N70 in zwitterionic membranes (see Fig. 3) [75]. These studies sug-
gest that the membrane inserted β-sheet FP can act as the primary de-
terminant for assembly of gp41 trimers in the membrane [75]. A
β-structured FP as an N-terminal appendage just downstream from
the NHR suggests parallel strand assembly for discrete trimers, while
additional structural models need to be considered for oligomerization
of gp41 trimers through assembly of FP β-strands.
1.5.4.3. Isotope edited FTIR to directly assign structure to the membrane
associated fusion peptide in context of a key gp41 structural motif
Isotope edited FTIR is a method of choice since it allows identiﬁcation
of residue-speciﬁc or region-speciﬁc secondary structure out of the globalsecondary structure of a protein or a peptide in different environments,
including orderedmembranes. Isotope labelinghas no effect on the struc-
ture or function of proteins. Therefore, this method can be used to map
secondary structure of individual residues or stretches of residues in
short or long polypeptides (proteins) [13,23,69,78–86]. The C;O vibra-
tion is sensitive to the masses of its component atoms. By replacing 12C
with 13C, a redshift of approximately 20–40 cm−1 is observed in the ab-
sorption. This translates to the appearance of a new 13C;O peak signiﬁ-
cantly down-shifted in frequency, along with a reduction in intensity of
the original 12C;O peak. For β-type structures, this original 12C;O peak
is further subject to amild up-shift in frequency. Based on the peak shifts
caused by the labeled residue(s), site speciﬁc or region speciﬁc secondary
structure is directly assigned [13,23,69,78–86]. With this system in hand,
Sackett and Shai speciﬁcally labeled with 13C different regions within
N70. The labeling scheme is shown in Fig. 4. Based on peak shift of
the labeled regions, predominant β-sheet conformation was unambigu-
ously assigned to the FP region, and the unlabeled NHR region was
predominantly helical within zwitterionic membranes [87]. Because the
FP is an N-terminal appendage, it can retain this structure and function
in context of the folded core as well. In context of gp41, the assembly is
minimally trimeric for the gp41 trimer [87]. Overall, this direct structural
identiﬁcation of the FP inmembranes in context of N70 provided the ﬁrst
evidence of a molecular mechanism for assembly of gp41 trimers during
fusion [87]. The extended β-sheets present an extensive oligomerization
interface on both sides of the sheet, which can seed assembly, via the FP,
of gp41 trimers during fusion.
Whereas the absorbance frequency shift is primarily determined
by change in nuclear mass for isotope enriched samples based on a
simple harmonic oscillator model, Transition Dipole Coupling (TDC)
can have a signiﬁcant and a lesser effect on peak absorption intensity
and frequency, respectively, in the case of β-sheet peptide conforma-
tion [88,89]. Speciﬁcally, β-sheet inter-strand alignment of a 13C;O
with a 12C;O nuclei results in Amide I absorption with enhanced in-
tensity and frequency for the single label. For an alternate scenario,
with alignment of single 13C;O labels between strands, the main re-
sult of TDC will be absorbance shift to lower frequency for the single
strand labels. Therefore, minimal and differential labeling, coupled
with analysis of labeled peak absorption frequency and intensity
can be used to determine strand alignment using isotope-edited IR.
For longer polypeptides, labeled shift resolution may be challenging
for single site labeling, and caution must be exercised in both labeling
and interpretation. Speciﬁcally, for the N70 isotope-edited FTIR study,
cassettes of adjacent labeled residues were engineered to resolve
changes in shifts from the FP region (~16 residues) out of large
unlabeled NHR signals (~54 residues). With adjacent residue 13C;O
labeling, both intra- and inter-strand TDC affects must be considered.
The initial FP strand alignment interpretation of 13C;O cassette labeled
Fig. 3. Illustration depicting the membrane interacting secondary structure of a N70 monomer based on the characterization of wild type (WT) and mutant N70 in PC membranes
using FTIR. The upper left panel shows the spectrum of the N70-WT which is composed of a β-sheet component and an α-helix component. In the upper right site mutation was
done in the loop in which two Gly were inserted (N70-GG). This mutation did not affect the overall structure of the mutant suggesting that it does not contribute to the α-helix or
β-sheet component. The lower left side shows the spectrum of the mutant N70-F11G in which the mutation was done in the FP. This mutation signiﬁcantly reduced the β-sheet
component. Finally, mutation in the NHR reduced signiﬁcantly the α-helix component as indicated in the right lower panel for N70-I62D (modiﬁed from ref. [75]).
2311Y. Shai / Biochimica et Biophysica Acta 1828 (2013) 2306–2313N70 did not consider intra-strand TDC affects, and therefore we cannot
rule-out contributions from likely anti-parallel alignment/registries.
A structural model describing the organization of membrane asso-
ciated FP in context of key gp41 functional regions has important
biological relevance. Speciﬁcally, the ability of synthetic FP derived
peptides to inhibit gp41 mediated cell fusion [50] can be explained by
a FTIR model which speciﬁes a FP β-sheet structural template that
serves to direct co-assembly between discrete FP fragments and the
FP region of N70 inmembranes. This suggests that the inhibitory action
of free FP peptides is based on disruption of higher order gp41 assembly
directed by the viral FP region, and such inhibition can occur at an early
stage (PHI) of gp41 mediated membrane fusion. Free FP fragments
are expected to co-assemble with, and may intercalate with viral FPFig. 4. A cartoon illustrating the 13C labeling scheme. Designations are: fusion peptide mar
(modiﬁed from ref. [87]).β-sheets in membranes thereby competitively inhibiting proper gp41
assembly through viral FP regions required for fusion competence [87].
In summary, because of the long IR wavelength, light scattering
problems are virtually non-existent and highly aggregated materials
or large membrane fragments can be investigated. A unique advan-
tage of infrared spectroscopy is that it allows simultaneous study of
the structure of lipids and proteins in intact biological membranes
without introduction of foreign perturbing probes.
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